Lexicon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update Commercial launch of INPEFA® (sotagliflozin) for Heart Failure continues to progress Resubmission of NDA for ZYNQUISTA™ (sotagliflozin) in Type 1 Diabetes expected mid-year 2024 Start-up ongoing for Phase 3 study of sotagliflozin in Hypertrophic Cardiomyopathy, with enrollment expected to begin mid-year 2024 Enrollment in Phase 2b PROGRESS study of LX9211 in Diabetic Peripheral Neuropathic Pain on track for expected Q2 2025 topline data Conference Call and Webcast at 5:00 pm Eastern Time ...
Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024 ALPHARETTA, Ga., April 30, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that its first quarter 2024 financial results will be reported on Thursday, May 9, 2024 after the close of the financial markets. Management will host a webcast and conference call at 4:30 p.m. Eastern Time to discuss the result...
Lonnel Coats Retires as Chief Executive Officer and Board Member of Lexicon Pharmaceuticals THE WOODLANDS, Texas, April 29, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) today announced that Lonnel Coats has provided notice of his retirement as chief executive officer and as a member of its board of directors, in each case effective July 7, 2024, his 10th anniversary with the company. The board of directors has initiated a search for a new chief executive officer which will consider both internal and external candidates. “During Mr. Coats’ tenure, Lexicon advanced two compounds through clin...
Lexicon Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 2, 2024 THE WOODLANDS, Texas, April 29, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) will release its first quarter 2024 financial results on Thursday, May 2, 2024 after the markets close. Management will conduct a conference call and live webcast at 5:00 p.m. ET (4:00 p.m. CT) that day to discuss the financial results and to provide a business update. Dial-in InformationU.S. Dial-in Number: (888) 317-6003International Dial-in Number: (412) 317-6061Conference ID: 5993982 Replay Informatio...
NETSOL Technologies Sets Fiscal Third Quarter 2024 Conference Call for Thursday, May 9 at 9:00 am ET ENCINO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- NETSOL Technologies, Inc. (Nasdaq: NTWK), a global business services and enterprise application solutions provider, will hold a conference call on Thursday, May 9, 2024, at 9:00 a.m. Eastern Time (6:00 a.m. Pacific Time) to discuss its financial results for the fiscal third quarter of 2024 ended March 31, 2024. Financial results will be issued in a press release prior to the call. Following the call, management will host a question-and-ans...
A director at Clearside Biomedical Inc maiden bought 100,000 shares at 1.297USD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
Lexicon Pharmaceuticals to Host 2024 Investor Day Includes Business and Scientific Updates from Lexicon Executives and Leading Medical Experts in Hypertrophic Cardiomyopathy, Type 1 Diabetes and Diabetic Peripheral Neuropathic Pain THE WOODLANDS, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) today announced that senior company executives will be joined by leading physicians at the Lexicon 2024 Investor Day on April 22, 2024. The event will be held in New York City from 9:00 a.m. to 12:00 p.m. ET. Business and scientific updates will be presented by Lonnel Coats, Lexicon’s c...
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors - Appointment Adds Broad Expertise in Business Strategy, Collaborations, Finance, and M&A with Recent Ophthalmic Experience - ALPHARETTA, Ga., April 16, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that Anthony S. Gibney has been appointed to the Company's Board of Directors, effective April 15, 2024. “We are...
Leading German Auto Finance Company Goes Live with Full NFS Ascent Suite to Support Operations in South Korea ENCINO, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- NETSOL Technologies, Inc. (Nasdaq: NTWK), the global leader in delivering state-of-the-art solutions for the asset finance and leasing industry, has announced the go-live of its next-generation platform NFS Ascent for a leading German auto captive finance company and longstanding client to support their operations in South Korea. This deployment consisted of the full NFS Ascent suite, which includes both the Retail and the Wholesa...
Lexicon Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference THE WOODLANDS, Texas, April 03, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) today announced Jeff Wade, Lexicon’s president and chief financial officer, Tom Garner, Lexicon’s senior vice president and chief commercial officer, and Craig Granowitz, M.D., Ph.D., Lexicon’s senior vice president and chief medical officer, will participate in a moderated discussion at the 23rd Annual Needham Virtual Healthcare conference Wednesday April 10th, 1:30-2:10pm. A simultaneous webcast will be available in the...
NETSOL Technologies Achieves AWS Foundational Technical Review Badges for Five Products ENCINO, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- NETSOL Technologies, Inc. (Nasdaq: ), the global leader in delivering state-of-the-art solutions for the asset finance and leasing industry, has announced its achievement of the Amazon Web Services (AWS) Foundational Technical Review badges - a testament to its exceptional expertise in cloud technologies. This achievement is in recognition of five of NETSOL’s cloud-based, API-first solutions that are part of Appex Now – the Company’s marketplace of pro...
Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference ALPHARETTA, Ga., April 02, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that George Lasezkay, Pharm.D., J.D., President and Chief Executive Officer, and Victor Chong, M.D., MBA, Chief Medical Officer, will participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, Apri...
Close Brothers Goes Live with NETSOL's Cloud-Based Calculation Engine Flex ENCINO, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- NETSOL Technologies, Inc. (Nasdaq: NTWK), the global leader in delivering state-of-the-art solutions for the asset finance and leasing industry, has announced that Close Brothers, a leading UK merchant banking group providing lending, deposit taking, wealth management services and securities trading, had signed-up for and has subsequently gone live with the Company’s calculation engine Flex. The Flex cloud-based calculation engine enables affordability checks, rev...
Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo THE WOODLANDS, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) today announced that four data presentations related to sotagliflozin, an inhibitor of two sodium glucose transport proteins (SGLT2 and SGLT1), will be delivered during the American College of Cardiology 73rd Annual Scientific Session & Expo being held April 6 - 8, 2024 in Atlanta, Georgia, including results from a post-hoc ...
NETSOL Technologies, Inc. Achieves Advanced Tier Partner Status with Amazon Web Services ENCINO, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- NETSOL Technologies, Inc. (Nasdaq: NTWK), the global leader in delivering state-of-the-art solutions for the asset finance and leasing industry, has announced that it has achieved the Advanced Tier Services Partner status within the Amazon Web Services (AWS) Partner Network (APN). Partners who demonstrate exceptional prominence, emerge as industry leaders in their respective markets and have a highly proficient workforce receive this status. This mil...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.